At Hôpital Albert Schweitzer, the sickle cell clinic provides consistent, specialized care for children living with complex and lifelong conditions. For many families in the Artibonite Valley, these regular visits have become an essential part of care, offering not only medical support, but also guidance and reassurance as they navigate the challenges of sickle cell disease over time.
Held several times throughout the year, the clinic is designed to provide comprehensive, ongoing care. Each visit includes a review of laboratory results, a physical examination, and any necessary adjustments to medications or treatment plans. Families also receive guidance on managing symptoms at home, and follow-up testing is scheduled to ensure that each child continues to receive consistent care between visits.
For families, managing sickle cell disease at home can be challenging. Children may experience recurring pain crises, frequent infections, and disruptions to daily life, often creating stress and uncertainty for parents. Through the clinic, education and counseling help families better understand the condition, reducing fear and allowing them to feel more confident in caring for their children. Over time, this support helps families build routines and develop a stronger sense of stability in managing the illness.
This consistency leads to meaningful improvements. Children begin taking their medications more regularly, complications become less frequent, and overall health improves. Just as importantly, families feel more supported and better equipped to manage care at home, with a clearer understanding of how to respond when challenges arise.
One experience from the clinic reflects the impact of this work. Two children who had been frequently hospitalized were not able to attend visits regularly, as financial barriers made it difficult for their family to come. When the care team learned this, support was put in place so they could return consistently. With regular care, their health improved significantly, and they have not been hospitalized since.
As the program continues to grow, so does understanding within the community, helping to reduce stigma and misconceptions around sickle cell disease. Families are becoming more informed, and more confident in seeking care and supporting their children over time.
Looking ahead, strengthening early detection through neonatal screening and ensuring access to essential medications like hydroxyurea will be critical to improving outcomes. Together, these efforts help ensure that children and their families have access to the consistent care, support, and stability they need for the future.